A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Norgestrel EP Impurity I - Request Quote

Picture of Norgestrel EP Impurity I

Norgestrel EP Impurity I

SZ CAT No:SZ-N060011
CAS No
NA
Mol.F.
C38H54O4
Mol.Wt.
574.8
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Norgestrel EP Impurity I is chemically All-ξ-13,13′-diethyl-17,17′-dihydroxy-17,17′-bigona-4,4′-diene-3,3′-dione (as per EP). Norgestrel EP Impurity I is supplied with detailed characterization data compliant with regulatory guideline. Norgestrel EP Impurity I can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Norgestrel.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Norgestrel EP Impurity I

Purchase Norgestrel EP Impurity I

Norgestrel EP Impurity I suppliers

Norgestrel EP Impurity I manufacturers

Norgestrel EP Impurity I price

Order Norgestrel EP Impurity I

Enquire Norgestrel EP Impurity I

Norgestrel EP Impurity I cost

Norgestrel EP Impurity I Supplier

Norgestrel EP Impurity I Distributor

Norgestrel EP Impurity I for Method Validation

Norgestrel Reference Standard

Norgestrel EP Impurity I for ANDA Filing

Norgestrel EP Impurity I for Forced Degradation Studies

Norgestrel EP Impurity I Identification Standards

Norgestrel EP Impurity I for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,